A picture of the covid-19 impact on IVIRMA fertility treatment clinics in Spain and Italy

Reprod Biomed Online. 2020 Jul;41(1):1-5. doi: 10.1016/j.rbmo.2020.04.015. Epub 2020 Apr 25.

Abstract

The emergence of the novel coronavirus infection that arose in Wuhan, China in December 2019 has resulted in an epidemic that has quickly expanded to become one of the most significant public health threats in recent times. Unfortunately, the disease has spread globally. On March 11th (2020) World Health Organization (WHO) declared Covid-19 a pandemic and has called governments to take urgent and aggressive action to change the course of the outbreak. Within the context of Assisted Reproduction, both reproductive medicine professionals and patients are also fighting against this unprecedented viral pandemic. In view of events, most of us had to make serious decisions, some of them with a lack of scientific evidence due to the circumstances and with the only objective of ensuring the safe care of our patients, reduce non-essential contacts and prevent possible maternal and fetal complications in future pregnancies. Pregnant women should not be considered at high risk for developing severe infection. Up to date, there are no reported deaths in pregnant women with Covid-19, while in the cases that have presented pneumonia because of Covid-19, the symptoms have been moderate and with a good prognosis in recovery.

Keywords: Assisted reproduction; Covid-19; Pregnancy.

MeSH terms

  • COVID-19
  • Coronavirus Infections / epidemiology*
  • Female
  • Fertility Clinics*
  • Guidelines as Topic
  • Humans
  • Infertility / therapy
  • Italy
  • Maternal Age
  • Pandemics
  • Patient Care
  • Pneumonia, Viral / epidemiology*
  • Pregnancy
  • Reproductive Health Services*
  • Reproductive Techniques, Assisted
  • Spain
  • Time Factors